Neoadjuvant Therapy And Surgery In Rectal Adenocarcinoma: Analysis Of Patients With Complete Tumor Remission [terapia Neoadjuvante E Cirurgia No Adenocarcinoma Retal: Análise Dos Pacientes Com Remissão Tumoral Completa No Reto]

Introduction: the standard treatment for locally advanced extra-peritoneal rectal adenocarcinoma, consists of neoadjuvant treatment with radiotherapy and chemotherapy followed by total mesorectal excision. Objective: evaluate, retrospectively, the patients submitted to neoadjuvant therapy and surgery that presents with total remission of the lesion in the anatomopathological examination. Methods: between 2000 and 2010, 212 patients underwent surgery at the Coloproctology Unit at DMAD at FCM-UNICAMP. They were grouped as: rectosigmoidectomy and colorectal anastomosis (n = 54), rectosigmoidectomy with coloanal anastomosis (n = 41), 114 abdominoperineal resection of the rectum (n = 114) and other (n = 3). Results: thirty (14.2%) patients (mean age 57.6 years; 60% males) showed complete remission of the rectal lesion. 4 (13.3%) had compromised lymph nodes and/or lymphatic invasion At follow-up (mean 51.9 months), 4 (13.3%) presented with local recurrence (one patient) or distant metastases (two patients had liver metastasis, one had liver and lung, and one had bone metastasis). The mean survival was 86.7%. Conclusion: patients with a complete tumor response show ed an increased survival rate, however, the same patients without evidence of residual tumors could develop local recurrence or distant metastases on a later follow-up. © 2013 Elsevier Editora Ltda. All rights reserved.334222227Castaldo, E.T., Parikh, A.A., Pinson, W., Feurer, I.D., Merchant, N.B., Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer (2009) Arch Surg, 144, pp. 129-134Instituto Nacional De Câncer (INCA), , http://www2.inca.gov.br/wps/wcm/connect/tiposdecancer/site/home/colorretal/definicaoHabr-Gama, A., Perez, R.O., Nadalin, W., Sabbaga, J., Ribeiro Jr., U., de Silva Jr., A.H.S., Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results (2004) Ann Surg, 240 (4), pp. 711-717Habr-Gama, A., Assessment and management of the complete clinical response of rectal cancer to chemoradiotherapy Colorectal Dis 20068 Suppl, 3, pp. 21-24Altenburg, F.L., Biondo-Simões, M.L.P., Bahten, L.C., A pesquisa de sangue oculto nas fezes associada a um questionário de sinais e sintomas na prevenção do câncer colorretal (2009) Rev Bras Coloproct, 29 (1), pp. 57-64Bipat, S., Glas, A.S., Slors, F.J.M., Zwinderman, A.H., Bossuyt, P.M.M., Stoker, J., Rectal cancer: Local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis (2004) Radiology, 232 (3), pp. 773-783Habr-Gama, A., Perez, R.O., Julião, G.P.S., Proscurshim, I., Gama-Rodrigues, J., Nonoperative approaches to rectal cancer: A critical evaluation (2011) Semin Radiat Oncol, 21 (3), pp. 234-239Habr-Gama, A., Perez, R.O., Julião, G.P.S., Proscurshim, I., Gama-Rodrigues, J., Complete clinical response after neoadjuvant chemoradiation for distal rectal cancer (2010) Surg Oncol Clin N Am, 19, pp. 829-845Maas, M., Beets-Tan, R.G., Lambregts, D.M., Lammmering, G., Nelemans, P.J., Engelen, S.M., Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer (2011) J Clin Oncol, 29 (35), pp. 4633-4640Smith, J.D., Ruby, J.A., Goodman, K.A., Saltz, L.B., Guillem, J.G., Weiser, M.R., Nonoperative management of rectal cancer with complete clinical response after neoadjuvant therapy (2012) Ann Surg, 256 (6), pp. 965-972Wichmann, M.W., Muller, C., Meyer, G., Straus, T., Hornung, H.M., Lau-Werner, U., Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer (2002) Arch Surg, 137, pp. 206-210Medich, D., McGinty, J., Parda, D., Karlovits, S., Davies, C., Caushaj, P., Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: Pathologic findings and clinical implications (2001) Dis Colon Rectum, 44, pp. 1123-1128Dulk, M., Velde, C.J.H., Considerations and restrictions for nonoperative treatment of rectal cancer in selected patients (2007) The Lancet Oncol, 8 (7), pp. 570-571Hiotis, S.P., Weber, S.M., Cohen, A.M., Minsky, B.D., Paty, P.B., Guillem, J.G., Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients (2002) J Am Coll Surg, 194, pp. 131-135Moore, H.G., Gittleman, A.E., Minsky, B.D., Wong, D., Paty, P.B., Weiser, M., Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection (2004) Dis Colon Rectum, 47, pp. 279-286Habr-Gama, A., Perez, R.O., Proscurshim, I., Santos, R.M.N., Kiss, D., Gama-Rodrigues, J., Interval between surgery and neoadjuvant chemoradiation therapy for distal rectal cancer: Does delayed surgery have an impact on outcome? (2008) Int J Radiat Oncol Biol Phys, 71 (4), pp. 1181-1188Nyasavajjala, S.M., Shaw, A.G., Khan, A.Q., Brown, S.R., Lund, J.N., Neoadjuvant chemo-radiotherapy and rectal cancer: Can the UK watch and wait with Brazil? (2009) Colorectal Dis, 12, pp. 33-36Sloothaak, D.A., Geijsen, D.E., van Leersum, N.J., Punt, C.J., Buskens, C.J., Bemelman, W.A., Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer (2013) Br J Surg, 100 (7), pp. 933-939Pinho, M., Resposta completa à terapia neoadjuvante no câncer de reto: Apenas sorte ou um resultado previsível? (2007) Rev Bras Coloproct, 27 (4), pp. 474-478Perez, R.O., Habr-Gama, A., Gama-Rodrigues, J., Proscurshim, I., Julião, G.P.S., Lynn, P., Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation (2012) Cancer, 15, pp. 3501-3511Issa, N., Murninkas, A., Powsner, E., Dreznick, Z., Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer (2012) World J Surg, 36 (10), pp. 2481-2487Belluco, C., de Paoli, A., Canzonieri, V., Sigon, R., Fornasarig, M., Buonadonna, A., Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: Implications for local excision surgical strategies (2011) Ann Surg Oncol, 18 (13), pp. 3686-3693Campos-Lobato, L.F., Stocchi, L., Moreira, L.A., Geisler, D., Dietz, D.W., Lavery, I.C., Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence (2011) Ann Surg Oncol, 18 (6), pp. 1590-1598Maas, M., Nelemans, P.J., Valentini, V., Das, P., Rödel, C., Kuo, L.J., Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: A pooled analysis of individual patient data (2010) Lancet Oncol, 11 (9), pp. 835-844Martin, S.T., Heneghan, H.M., Winter, D.C., Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer (2012) Br J Surg, 99 (7), pp. 918-928Zorcolo, L., Rosman, A.S., Restivo, A., Pisano, M., Nigri, G.R., Fancellu, A., Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: A meta-analysis (2012) Ann Surg Oncol, 19 (9), pp. 2822-2832Smith, F.M., Chang, K.H., Sheahan, K., Hyland, J., O'Connell, P.R., Winter, D.C., The surgical significance of residual mucosal abnormalities in rectal cancer following neoadjuvant chemoradiotherapy (2012) Br J Surg, 99 (7), pp. 993-1001Tranchart, H., Lefèvre, J.H., Svrcek, M., Flejou, J.F., Tiret, E., Parc, Y., What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer (2012) Ann Surg Oncol, , nov 28 [Epub ahead of print]Habr-Gama, A., Perez, R.O., Proscurshim, I., Campos, F.G., Nadalin, W., Kiss, D.R., Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy (2006) J Gastrointest Surg, 10, pp. 1319-1329Stipa, F., Zernecke, A., Moore, H.G., Minsky, B.D., Wong, W.D., Weiser, M., Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: Rationale for radical resection? (2004) Ann Surg Oncol, 11, pp. 187-19